Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

BIO-TECHNE Corp Director's Dealing 2016

May 19, 2016

30718_dirs_2016-05-19_5d6edd17-ec41-45c8-ba50-1320f9591e93.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: BIO-TECHNE Corp (TECH)
CIK: 0000842023
Period of Report: 2016-05-18

Reporting Person: LUCAS ROGER C (N/A)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2016-05-18 Common Stock S 100.00 $102.53 Disposed 3815.00 Direct

Holdings (Derivative)

Security Exercise Price Expiration Underlying Shares Ownership
Stock Options (Right to Buy) $91.78 2024-10-30 Common Stock (4000.00) 4000.00 Direct
Stock Options (Right to Buy) $87.39 2023-10-30 Common Stock (4000.00) 4000.00 Direct
Stock Options (Right to Buy) $87.34 2025-10-28 Common Stock (4260.00) 4260.00 Direct

Footnotes

F1: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on February 12, 2016.